|
NPM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.404000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.601380E-01 |
| Normal-vs-Stage2 |
6.336400E-01 |
| Normal-vs-Stage3 |
3.004400E-01 |
| Normal-vs-Stage4 |
3.939600E-03 |
| Stage1-vs-Stage2 |
7.049400E-01 |
| Stage1-vs-Stage3 |
8.353600E-01 |
| Stage1-vs-Stage4 |
2.402200E-02 |
| Stage2-vs-Stage3 |
8.446200E-01 |
| Stage2-vs-Stage4 |
4.938200E-02 |
| Stage3-vs-Stage4 |
2.362000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.250200E-02 |
| Normal-vs-AfricanAmerican |
1.294600E-01 |
| Normal-vs-Asian |
2.782800E-01 |
| Caucasian-vs-AfricanAmerican |
5.557800E-01 |
| Caucasian-vs-Asian |
8.956800E-01 |
| AfricanAmerican-vs-Asian |
5.098400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.073600E-02 |
| Normal-vs-Female |
9.578300E-02 |
| Male-vs-Female |
6.633400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.114030E-01 |
| Normal-vs-Age(41-60Yrs) |
1.484380E-01 |
| Normal-vs-Age(61-80Yrs) |
1.418220E-01 |
| Normal-vs-Age(81-100Yrs) |
8.544600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.142200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.892800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.620200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.581400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.062000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.594200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.962800E-01 |
| Classical-VS-Follicular |
1.583660E-02 |
| Classical-VS-Other |
8.067200E-01 |
| Classical-VS-Normal |
9.918400E-03 |
| Tall-VS-Follicular |
4.460100E-02 |
| Tall-VS-Other |
9.095000E-01 |
| Tall-VS-Normal |
4.342100E-02 |
| Follicular-VS-Other |
3.444400E-01 |
| Follicular-VS-Normal |
7.483800E-01 |
| Other-VS-Normal |
4.258400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.107800E-01 |
| Normal-vs-N1 |
2.646000E-01 |
| N0-vs-N1 |
4.070600E-01 |
|
|
